Back
Werewolf Therapeutics, Inc. 10K Form
Sell
23
HOWL
Werewolf Therapeutics, Inc.
Last Price:
$1.00
Seasonality Move:
29.54%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive HOWL News And Ratings
See the #1 stock for the next 7 days that we like better than HOWL
HOWL Financial Statistics
Sales & Book Value
| Annual Sales: | $1.9M |
|---|---|
| Cash Flow: | $-15.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.63 |
| Price / Book: | 1.56 |
Profitability
| EPS (TTM): | -1.61930 |
|---|---|
| Net Income (TTM): | $-72.8M |
| Gross Margin: | $71K |
| Return on Equity: | -125.09% |
| Return on Assets: | -66.34% |
Werewolf Therapeutics, Inc. Earnings Forecast
Key Werewolf Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 4 years for HOWL is 3.77%.
-
The Selling, General & Administrative Expenses for HOWL have been equal to 1,010.34% of Gross Profit Margin.
-
The Research & Development expenses have been 2,993.85% of Revenue.
-
The Net Earning history of HOWL is -3,740.85% of Total Revenues.
-
Per Share Earnings over the last 6 years have been positive in 2 years.
Werewolf Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | HOWL |
| Website: | werewolftx.com |
Debt
| Debt-to-Equity Ratio: | 1.26 |
|---|---|
| Current Ratio: | 3.87 |
| Quick Ratio: | 3.73 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
HOWL Technical Analysis vs Fundamental Analysis
Sell
23
Werewolf Therapeutics, Inc. (HOWL)
is a Sell
Is Werewolf Therapeutics, Inc. a Buy or a Sell?
-
Werewolf Therapeutics, Inc. stock is rated a SellThe current Werewolf Therapeutics, Inc. [HOWL] share price is $0.95. The Score for HOWL is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.